Clinical Trial Update: Glutamate for Metabolic Intervention in Coronary Surgery II [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on glutamate-based metabolic intervention in coronary surgery completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heart Failure

Snippet

Sponsor: University Hospital, Linkoeping | Conditions: Coronary Artery Bypass Surgery, Postoperative Complications | Phase 3 | Status: COMPLETED | Results posted: 2023-12-04